View on Pubmed.gov 34228490 | View on doi.org 10.1128/IAI.002...
Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.
- Department of Medicine, University of Washington, Seattle, Washington, USA.
- Vaccine Science, International Center for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Infectious Diseases, Massachusetts General Hospitalgrid.32224.35, Boston, Massachusetts, USA.
- Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Global Health, Massachusetts General Hospitalgrid.32224.35 for Children, Boston, Massachusetts, USA.
Abstract
Cholera is a diarrheal disease caused by Vibrio cholerae that continues to be a major public health concern in populations without access to safe water. IgG- and IgA-secreting memory B cells (MBC) targeting the V. cholerae O-specific polysaccharide (OSP) correlate with protection from infection in persons exposed to V. cholerae and may be a major determinant of long-term protection against cholera. Shanchol, a widely used oral cholera vaccine (OCV), stimulates OSP MBC responses in only some people after vaccination, and the gut microbiota is a possible determinant of variable immune responses observed after OCV. Using 16S rRNA sequencing of feces from the time of vaccination, we compared the gut microbiota among adults with and without MBC responses to OCV. Gut microbial diversity measures were not associated with MBC isotype or OSP-specific responses, but individuals with a higher abundance of and lower abundance of were more likely to develop an MBC response. We applied protein-normalized fecal supernatants of high and low MBC responders to THP-1-derived human macrophages to investigate the effect of microbial factors at the time of vaccination. Feces from individuals with higher MBC responses induced significantly different IL-1β and IL-6 levels than individuals with lower responses, indicating that the gut microbiota at the time of vaccination may "prime" the mucosal immune response to vaccine antigens. Our results suggest the gut microbiota could impact immune responses to OCVs, and further study of microbial metabolites as potential vaccine adjuvants is warranted.
References
PLoS Pathog. 2014 Oct 02;10(10):e1004405
PLoS One. 2012;7(2):e30126
Vaccine. 2016 Mar 18;34(13):1551-1558
Cell Host Microbe. 2016 Aug 10;20(2):202-14
Cited by 20 citations (total)
Journal Article
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
Electronic publication date November 25, 2023
Aleix Elizalde-Torrent [...] Alex Olvera et al.
Despite the important role of gut microbiota in the maturation of the immune system, little is known about its impact...
Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh.
Electronic publication date January 11, 2023
Fahima Chowdhury [...] Firdausi Qadri et al.
Background
Immune responses that target sialidase occur following natural cholera and have been associated with protection against cholera. Sialidase is a...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •